Octreotide acetate

Cat. No.: PI79517014

Description: Octreotide acetate is the current primary treatment for patients with acromegaly, together with other somatostatin analogue, Lanreotide.

Product Details

CAS	79517-01-4
Molecular Formula	C49H66N10O10S2
Molecular Weight	1019.2
Available Formulations	Injectables Injectables Long-Acting
Available DMF/CEP/GMP	EU DMF, US DMF

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *

For product and service inquiries, please use our online system or send an email to .